23/07/2024
Researchers at Macquarie University are recruiting participants for a clinical trial investigating microdosing with psilocybin as a treatment for depression.
This trial uses very low doses, not expected to lead to alterations in consciousness.
Participants will take part in a six week intervention, with two doses per week.
Participants are monitored by a psychiatrist throughout the intervention.
